Site Map Understanding Cancer About Lung Cancer Types of Non-Small Cell Lung Cancer Symptoms Diagnosis and Staging About Pancreatic Cancer Symptoms Treatment Surgery as a Treatment Option What Happens After Surgery If the Tumor Can't be Removed by Surgery Living With Cancer of the Pancreas About Breast Cancer Types of Breast Cancer Early Detection and Screening Diagnosis Staging Symptoms & Treatment About Ovarian Cancer Types of Ovarian Cancer Symptoms Diagnosis and Staging Treatment of Ovarian Cancer Side Effects of Chemotherapy Treatment Options Considering Your Treatment Options How Well Did Treatments Work? About Clinical Trials Types of Clinical Trials Participating in a Clinical Trial Researching the Results of Clinical Trials Find Out More About Clinical Trials Deciding Whether Clinical Trials Are Right for You How Well Did Treatments Work? Glossary Resources Online Resources for Patients and Caregivers For Healthcare Professionals Screensavers Before You Begin Therapy Guide to Making Decisions About Cancer Therapy Introduction Seeking Support Choosing a Healthcare Team Seeking Information What Do I Need to Know About Clinical Trials? Understanding Your Treatment Options Other Considerations Researching Treatment Options Seeking Support Education and Support Contacts Standard Therapy The Importance of Clinical Trials Compare Clinical Trial Results Find the Best Therapy for You Continuing Your Research Useful Links Before You Begin Chemotherapy—– Information About Side Effects You Do Have a Choice Understanding Treatment Options Potential Side Effects of Chemotherapy Therapy Planner Treatment With GEMZAR Reasons to Consider Chemotherapy Understanding Chemotherapy How Chemotherapy is Used Potential Side Effects of Chemotherapy GEMZAR for Non-Small Cell Lung Cancer How GEMZAR Can Help Side Effects GEMZAR for Pancreatic Cancer How GEMZAR Can Help Side Effects GEMZAR for Metastatic Breast Cancer How GEMZAR Can Help Side Effects GEMZAR for Ovarian Cancer How GEMZAR Is Given Side Effects Understanding Side Effects GEMZAR and Pancreatic Cancer GEMZAR and Non-Small Cell Lung Cancer GEMZAR and Metastatic Breast Cancer GEMZAR and Ovarian Cancer GEMZAR FAQs Life Stories Randy Stein Caregiver Resources What to Expect Aiding the Patient Understanding the Patient's Treatment Process Clinical Trials Treatment Considerations and Care Emotional Support Caring for the Caregiver Caregiver Tools A Caregiver's Story Support Resources For Healthcare Professionals GEMZAR and Non-Small Cell Lung Cancer Efficacy Data Dosage and Administration Safety Considerations GEMZAR and Pancreatic Cancer Efficacy Data Dosage and Administration Safety Considerations GEMZAR and Metastatic Breast Cancer Efficacy Data Dosage and Administration Safety Considerations GEMZAR and Ovarian Cancer Efficacy Data Dosage and Administration Safety Considerations Reimbursement Lilly Reimbursement Services Links For Your Patient Downloads Resources List Online Resources for Patients and Caregivers
Site Map  | Glossary  | Cancer Resources  | Calendar of Events  | GEMZAR FAQs  | Ask Lilly
Privacy Statement | Prescribing Information | Safety Information | Terms of Use Copyright © 2008 Eli Lilly and Company. All rights reserved. This site is intended for U.S. residents age 18 and over. For more information about cancer, contact your doctor or other healthcare professional. GEMZAR® is a registered trademark of Eli Lilly and Company. GC 28281 About GEMZAR GEMZAR in combination with paclitaxel is approved by the FDA for the first-line treatment of patients with metastatic breast cancer after they have received another type of chemotherapy called an anthracycline, unless their medical condition did not allow them to receive an anthracycline. GEMZAR is indicated in combination with cisplatin (another type of chemotherapy) for the first-line treatment of patients with locally advanced (stage IIIA or stage IIIB) or metastatic (stage IV or cancer that has spread) non-small cell lung cancer for whom surgery is not possible. GEMZAR is indicated as a single agent (given alone) as the first-line treatment for patients with locally advanced (stage II or stage III when surgery is not an option) or metastatic (stage IV) adenocarcinoma of the pancreas. GEMZAR is also indicated for patients previously treated with 5-FU (another type of chemotherapy). GEMZAR is indicated in combination with carboplatin (another type of chemotherapy) for the woman with ovarian cancer that has returned at least 6 months after the patient had finished platinum-based therapy. Important Safety Information GEMZAR may not be appropriate for some patients. If you are allergic to GEMZAR, tell your doctor you should not receive it. GEMZAR can suppress bone marrow function. There have been rare reports of serious kidney or liver toxicity with GEMZAR treatment, sometimes fatal. Serious lung toxicity has also been reported, sometimes fatal. If you think you are pregnant, are planning to be pregnant, or are nursing, please tell your healthcare team. GEMZAR may harm your unborn or nursing baby. If you have had prior kidney or liver problems or impairment, please tell your healthcare professional. GEMZAR may not be right for you. GEMZAR has not been shown to work in children. Tell your doctor if you are taking other medicines, including prescription and non-prescription medicines, vitamins, or herbal supplements. There is a risk of side effects associated with GEMZAR therapy. The most common side effects are low blood cell counts (red blood cells, white blood cells, and platelets); fever; infection; hair loss; tiredness; nausea, vomiting, constipation, and diarrhea; rash; shortness of breath; muscle aches; and numbness or tingling in your toes or fingers. These are not all of the side effects of GEMZAR. If you have any side effect that bothers you or that doesn't go away, be sure to talk with your healthcare professional. Call your healthcare professional right away if you have fever or chills. These symptoms could mean you have an infection. You will have regular blood tests before and during your treatment with GEMZAR. Your doctor may adjust your dose of GEMZAR or delay your treatment based on the results of your blood test and on your general condition. For more information about all of the side effects of GEMZAR, please talk with your healthcare team, see the complete Prescribing Information, or call 1-800-545-5979. SG-22